Clasp Therapeutics

Clasp Therapeutics is a biotechnology company dedicated to revolutionizing immuno-oncology treatments by developing off-the-shelf precision immunotherapies. Their approach involves targeting mutated protein fragments, or peptides, displayed on the surface of cancer cells, using proprietary pHLAre™ molecules. These molecules act as precision HLA redirecting engagers, attracting T cells to specifically destroy tumor cells while sparing healthy cells. This highly selective approach offers the potential to treat a wide range of cancers with a personalized approach, leading to improved treatment outcomes for patients.

Clasp Therapeutics is a fast-growing company with a team of experienced professionals dedicated to translating cutting-edge research into meaningful medicines. Their focus on innovation, collaboration, and patient-centricity has attracted a diverse and talented workforce. The company is backed by a strong network of investors and has received significant funding to support its ambitious goals. Clasp Therapeutics is poised to become a leader in the field of precision immuno-oncology, bringing hope to patients facing difficult-to-treat cancers.

Clasp Therapeutics offers a comprehensive benefits package that includes medical, dental, and vision insurance, a 401(k) plan, paid maternity and paternity leave, child care support, commuter benefits, and disability insurance. These benefits demonstrate their commitment to employee well-being and fostering a supportive work environment.

Clasp Therapeutics is a biotechnology company dedicated to transforming the lives of cancer patients by developing off-the-shelf precision immunotherapies. Their innovative approach leverages the immune system to target and destroy hard-to-treat tumors based on specific driver mutations, regardless of tumor type. Clasp's novel pHLAre molecules act as precision HLA redirecting engagers, drawing T cells into close contact with tumor cells and triggering their destruction while sparing healthy cells. This highly selective paradigm aims to offer a chance for response to treatment for a wide range of patients, expanding the reach of immuno-oncology and fulfilling their "Aim to Cure" mission.

Clasp Therapeutics fosters a collaborative and inclusive environment where team members are encouraged to contribute their ideas and work together towards the shared goal of developing innovative therapies. The company values passion, teamwork, and a deep commitment to translating cutting-edge research into meaningful medicines for patients.

Clasp Therapeutics is committed to fostering an inclusive and diverse workplace where all qualified applicants are considered for employment without regard to race, color, religion, sex, nationality, national or ethnic origin, civil status, age, citizenship status, sexual orientation, disability, marital or registered civil partnership status, pregnancy or parental status, gender identity, military or veteran status, or any other protected characteristic. They ensure that individuals with disabilities are provided reasonable accommodations to participate in the job application process.